SG11201503025WA - Rsv antiviral compounds - Google Patents
Rsv antiviral compoundsInfo
- Publication number
- SG11201503025WA SG11201503025WA SG11201503025WA SG11201503025WA SG11201503025WA SG 11201503025W A SG11201503025W A SG 11201503025WA SG 11201503025W A SG11201503025W A SG 11201503025WA SG 11201503025W A SG11201503025W A SG 11201503025WA SG 11201503025W A SG11201503025W A SG 11201503025WA
- Authority
- SG
- Singapore
- Prior art keywords
- antiviral compounds
- rsv antiviral
- rsv
- compounds
- antiviral
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12188694 | 2012-10-16 | ||
EP13159431 | 2013-03-15 | ||
PCT/EP2013/071525 WO2014060411A1 (en) | 2012-10-16 | 2013-10-15 | Rsv antiviral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201503025WA true SG11201503025WA (en) | 2015-06-29 |
Family
ID=49385250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201503025WA SG11201503025WA (en) | 2012-10-16 | 2013-10-15 | Rsv antiviral compounds |
Country Status (35)
Country | Link |
---|---|
US (1) | US9617289B2 (en) |
EP (1) | EP2909195B1 (en) |
JP (1) | JP6375300B2 (en) |
KR (1) | KR102280918B1 (en) |
CN (1) | CN104903313B (en) |
AR (1) | AR093020A1 (en) |
AU (1) | AU2013334001B2 (en) |
BR (1) | BR112015008325B1 (en) |
CA (1) | CA2884491C (en) |
CL (1) | CL2015000925A1 (en) |
CY (1) | CY1119566T1 (en) |
DK (1) | DK2909195T3 (en) |
EA (1) | EA026628B1 (en) |
EC (1) | ECSP15014941A (en) |
ES (1) | ES2640446T3 (en) |
HK (1) | HK1210462A1 (en) |
HR (1) | HRP20171351T1 (en) |
HU (1) | HUE033476T2 (en) |
IL (1) | IL237857A (en) |
LT (1) | LT2909195T (en) |
ME (1) | ME02835B (en) |
MX (1) | MX363717B (en) |
MY (1) | MY172021A (en) |
NZ (1) | NZ705759A (en) |
PE (1) | PE20150723A1 (en) |
PH (1) | PH12015500780B1 (en) |
PL (1) | PL2909195T3 (en) |
PT (1) | PT2909195T (en) |
SA (1) | SA515360258B1 (en) |
SG (1) | SG11201503025WA (en) |
SI (1) | SI2909195T1 (en) |
TW (1) | TWI598351B (en) |
UA (1) | UA114531C2 (en) |
WO (1) | WO2014060411A1 (en) |
ZA (1) | ZA201502532B (en) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI515187B (en) | 2010-12-16 | 2016-01-01 | 健生科學愛爾蘭無限公司 | Indoles as respiratory syncytial virus antiviral agents |
TWI501967B (en) * | 2010-12-16 | 2015-10-01 | Janssen R&D Ireland | Azaindoles as respiratory syncytial virus antiviral agents |
TWI527814B (en) | 2010-12-16 | 2016-04-01 | 健生科學愛爾蘭無限公司 | Azabenzimidazoles as respiratory syncytial virus antiviral agents |
SG11201406757SA (en) | 2012-04-26 | 2014-11-27 | Bristol Myers Squibb Co | Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
AR091455A1 (en) | 2012-06-15 | 2015-02-04 | Janssen R & D Ireland | DERIVATIVES 1,3-DIHIDRO-2H-BENZIMIDAZOL-2-ONA SUBSTITUTED WITH HETEROCICLES AS ANTIVIRAL AGENTS FOR RESPIRATORY SYNC VIRUS |
TWI568722B (en) | 2012-06-15 | 2017-02-01 | 葛蘭馬克製藥公司 | Triazolone compounds as mpges-1 inhibitors |
US9278950B2 (en) | 2013-01-14 | 2016-03-08 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
AR094664A1 (en) | 2013-01-15 | 2015-08-19 | Incyte Corp | THYZOLCARBOXAMIDS AND PYRIDINACARBOXAMIDE COMPOUNDS USED AS QUINASE PIM INHIBITORS |
CN105392787B (en) * | 2013-05-14 | 2017-11-24 | 豪夫迈·罗氏有限公司 | For treating and preventing the azepine oxindole of respiratory syncytial virus infection |
WO2014184163A1 (en) * | 2013-05-14 | 2014-11-20 | F. Hoffmann-La Roche Ag | Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection |
JP6211195B2 (en) * | 2013-08-12 | 2017-10-11 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Novel aza-oxo-indoles for the treatment and prevention of respiratory syncytial virus infection |
MX2016001858A (en) * | 2013-08-15 | 2016-05-24 | Hoffmann La Roche | Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection. |
US9556197B2 (en) | 2013-08-23 | 2017-01-31 | Incyte Corporation | Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors |
EP3081569B1 (en) * | 2013-12-10 | 2019-09-18 | Shandong Danhong Pharmaceutical Co., Ltd. | Imidazole derivative used as antiviral agent and use thereof in preparation of medicament |
TWI671299B (en) * | 2014-04-14 | 2019-09-11 | 愛爾蘭商健生科學愛爾蘭無限公司 | Spiro urea compounds as rsv antiviral compounds |
WO2016010897A1 (en) | 2014-07-14 | 2016-01-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors |
US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
GB201417707D0 (en) | 2014-10-07 | 2014-11-19 | Viral Ltd | Pharmaceutical compounds |
WO2016196244A1 (en) | 2015-05-29 | 2016-12-08 | Incyte Corporation | Pyridineamine compounds useful as pim kinase inhibitors |
ES2821649T3 (en) | 2015-06-08 | 2021-04-27 | Shangdong Danhong Pharmaceutical Co Ltd | Method for preparing imidazole derivatives and intermediates thereof and crystalline forms |
WO2017015449A1 (en) | 2015-07-22 | 2017-01-26 | Enanta Pharmaceuticals, Inc. | Benzodiazepine derivatives as rsv inhibitors |
AR105967A1 (en) | 2015-09-09 | 2017-11-29 | Incyte Corp | SALTS OF A PIM QUINASA INHIBITOR |
US9920032B2 (en) | 2015-10-02 | 2018-03-20 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
EP3380467B1 (en) | 2015-11-27 | 2021-07-07 | Janssen Sciences Ireland Unlimited Company | Heterocyclic indoles for use in influenza virus infection |
WO2017123884A1 (en) | 2016-01-15 | 2017-07-20 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as rsv inhibitors |
JP6989509B2 (en) | 2016-01-20 | 2022-01-05 | ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー | Aryl-substituted pyrimidines for use in influenza virus infection |
EP3414247B1 (en) * | 2016-02-08 | 2021-04-21 | F. Hoffmann-La Roche AG | Spiroindolinones as ddr1 inhibitors |
SI3494110T1 (en) | 2016-08-04 | 2021-12-31 | ReViral Limited | Pyrimidine derivatives and their use in treating or preventing a respiratory syncytial virus infection |
WO2018038668A1 (en) * | 2016-08-25 | 2018-03-01 | Medivir Ab | Respiratory syncytial virus inhibitors |
WO2018038667A1 (en) * | 2016-08-25 | 2018-03-01 | Medivir Ab | Respiratory syncytial virus inhibitors |
WO2018152413A1 (en) | 2017-02-16 | 2018-08-23 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of benzodiazepine derivatives |
US11091501B2 (en) | 2017-06-30 | 2021-08-17 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
GB201711704D0 (en) * | 2017-07-20 | 2017-09-06 | Reviral Ltd | Pharmaceutical compounds |
CN107383011B (en) * | 2017-08-01 | 2019-05-10 | 深圳百奥捷生物科技有限公司 | A kind of antiviral alkaloid and preparation method thereof being isolated from Folium Forsythia radix scutellariae |
CN107253951B (en) * | 2017-08-01 | 2019-05-10 | 深圳百奥捷生物科技有限公司 | A kind of purine alkaloid and its application as anti-RSV virus drugs |
CN109369658B (en) * | 2017-08-08 | 2020-01-31 | 沈阳药科大学 | Synthesis method of spiro [ pyrrolidine-3, 3' -oxindole ] ring systems |
WO2019067864A1 (en) | 2017-09-29 | 2019-04-04 | Enanta Pharmaceuticals, Inc. | Combination pharmaceutical agents as rsv inhibitors |
EP3710009A4 (en) | 2017-11-13 | 2021-08-25 | Enanta Pharmaceuticals, Inc. | Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives |
WO2019113487A1 (en) | 2017-12-08 | 2019-06-13 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
KR20210079278A (en) | 2018-09-06 | 2021-06-29 | 시다라 세라퓨틱스, 인코포레이티드 | Compositions and methods for the treatment of viral infections |
US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
WO2020168197A1 (en) | 2019-02-15 | 2020-08-20 | Incyte Corporation | Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors |
US11472791B2 (en) | 2019-03-05 | 2022-10-18 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors |
WO2020190935A1 (en) | 2019-03-18 | 2020-09-24 | Enanta Pharmaceuticals, Inc. | Benzodiazepine derivatives as rsv inhibitors |
US11919904B2 (en) | 2019-03-29 | 2024-03-05 | Incyte Corporation | Sulfonylamide compounds as CDK2 inhibitors |
WO2020223558A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | Tricyclic amine compounds as cdk2 inhibitors |
US11440914B2 (en) | 2019-05-01 | 2022-09-13 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
US20230082611A1 (en) * | 2019-06-13 | 2023-03-16 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of respiratory syncytial virus |
AR119765A1 (en) | 2019-08-14 | 2022-01-12 | Incyte Corp | IMIDAZOLIL PYRIMIDINILAMINE COMPOUNDS AS CDK2 INHIBITORS |
WO2021050612A1 (en) * | 2019-09-09 | 2021-03-18 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of respiratory syncytial virus |
US11505558B1 (en) | 2019-10-04 | 2022-11-22 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
WO2021066922A1 (en) | 2019-10-04 | 2021-04-08 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
WO2021072232A1 (en) | 2019-10-11 | 2021-04-15 | Incyte Corporation | Bicyclic amines as cdk2 inhibitors |
US20240109894A1 (en) * | 2019-10-30 | 2024-04-04 | Janssen Sciences Ireland Unlimited Company | Synthesis of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2-yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one |
CN114269747B (en) * | 2019-11-18 | 2023-04-18 | 苏州恩华生物医药科技有限公司 | 1',2' -dihydro-3'H-spiro [ cyclobutane 1,4' -isoquinoline ] -3' -one derivative and application thereof |
UY39032A (en) | 2020-01-24 | 2021-07-30 | Enanta Pharm Inc | HETEROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS |
US11534439B2 (en) | 2020-07-07 | 2022-12-27 | Enanta Pharmaceuticals, Inc. | Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors |
WO2022086840A1 (en) | 2020-10-19 | 2022-04-28 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as anti-viral agents |
JP2024507561A (en) | 2021-02-26 | 2024-02-20 | エナンタ ファーマシューティカルズ インコーポレイテッド | antiviral heterocyclic compounds |
WO2022184606A1 (en) * | 2021-03-01 | 2022-09-09 | Janssen Sciences Ireland Unlimited Company | Synthesis of rilematovir |
US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
CN117751124A (en) * | 2021-12-17 | 2024-03-22 | 南京药石科技股份有限公司 | Spiro oxindole compounds and application thereof in preparing antiviral protease inhibitor medicines |
WO2023200441A1 (en) * | 2022-04-13 | 2023-10-19 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489338B2 (en) | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
US6506738B1 (en) | 2000-09-27 | 2003-01-14 | Bristol-Myers Squibb Company | Benzimidazolone antiviral agents |
AR043692A1 (en) | 2003-02-06 | 2005-08-10 | Novartis Ag | 2-CYANOPIRROLOPIRIMIDINAS AND ITS PHARMACEUTICAL USES |
GB0304640D0 (en) * | 2003-02-28 | 2003-04-02 | Novartis Ag | Organic compounds |
TWI515187B (en) | 2010-12-16 | 2016-01-01 | 健生科學愛爾蘭無限公司 | Indoles as respiratory syncytial virus antiviral agents |
TWI501967B (en) | 2010-12-16 | 2015-10-01 | Janssen R&D Ireland | Azaindoles as respiratory syncytial virus antiviral agents |
TWI527814B (en) * | 2010-12-16 | 2016-04-01 | 健生科學愛爾蘭無限公司 | Azabenzimidazoles as respiratory syncytial virus antiviral agents |
TWI530495B (en) * | 2010-12-16 | 2016-04-21 | 健生科學愛爾蘭無限公司 | Benzimidazole respiratory syncytial virus inhibitors |
TWI541241B (en) * | 2010-12-16 | 2016-07-11 | 健生科學愛爾蘭無限公司 | Imidazopyridines as respiratory syncytial virus antiviral agents |
GB201119538D0 (en) | 2011-11-10 | 2011-12-21 | Viral Ltd | Pharmaceutical compounds |
-
2013
- 2013-10-15 SI SI201330771T patent/SI2909195T1/en unknown
- 2013-10-15 LT LTEP13779195.0T patent/LT2909195T/en unknown
- 2013-10-15 TW TW102137059A patent/TWI598351B/en active
- 2013-10-15 WO PCT/EP2013/071525 patent/WO2014060411A1/en active Application Filing
- 2013-10-15 PT PT137791950T patent/PT2909195T/en unknown
- 2013-10-15 AU AU2013334001A patent/AU2013334001B2/en active Active
- 2013-10-15 US US14/435,604 patent/US9617289B2/en active Active
- 2013-10-15 BR BR112015008325-0A patent/BR112015008325B1/en active IP Right Grant
- 2013-10-15 EA EA201590748A patent/EA026628B1/en not_active IP Right Cessation
- 2013-10-15 CA CA2884491A patent/CA2884491C/en active Active
- 2013-10-15 EP EP13779195.0A patent/EP2909195B1/en active Active
- 2013-10-15 PL PL13779195T patent/PL2909195T3/en unknown
- 2013-10-15 DK DK13779195.0T patent/DK2909195T3/en active
- 2013-10-15 AR ARP130103738A patent/AR093020A1/en active IP Right Grant
- 2013-10-15 ES ES13779195.0T patent/ES2640446T3/en active Active
- 2013-10-15 NZ NZ705759A patent/NZ705759A/en unknown
- 2013-10-15 SG SG11201503025WA patent/SG11201503025WA/en unknown
- 2013-10-15 CN CN201380053657.8A patent/CN104903313B/en active Active
- 2013-10-15 ME MEP-2017-210A patent/ME02835B/en unknown
- 2013-10-15 UA UAA201504703A patent/UA114531C2/en unknown
- 2013-10-15 HU HUE13779195A patent/HUE033476T2/en unknown
- 2013-10-15 MY MYPI2015000995A patent/MY172021A/en unknown
- 2013-10-15 MX MX2015004787A patent/MX363717B/en unknown
- 2013-10-15 JP JP2015537225A patent/JP6375300B2/en active Active
- 2013-10-15 KR KR1020157009775A patent/KR102280918B1/en active IP Right Grant
- 2013-10-15 PE PE2015000497A patent/PE20150723A1/en active IP Right Grant
-
2015
- 2015-03-22 IL IL237857A patent/IL237857A/en active IP Right Grant
- 2015-04-08 PH PH12015500780A patent/PH12015500780B1/en unknown
- 2015-04-09 SA SA515360258A patent/SA515360258B1/en unknown
- 2015-04-13 CL CL2015000925A patent/CL2015000925A1/en unknown
- 2015-04-15 ZA ZA2015/02532A patent/ZA201502532B/en unknown
- 2015-04-15 EC ECIEPI201514941A patent/ECSP15014941A/en unknown
- 2015-11-12 HK HK15111152.4A patent/HK1210462A1/en not_active IP Right Cessation
-
2017
- 2017-09-07 HR HRP20171351TT patent/HRP20171351T1/en unknown
- 2017-09-13 CY CY20171100965T patent/CY1119566T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20171351T1 (en) | Rsv antiviral compounds | |
HK1245263A1 (en) | Antiviral compounds | |
HK1250162A1 (en) | Antiviral compounds | |
HRP20181384T1 (en) | Condensed imidazolylimidazoles as antiviral compounds | |
SG10201703451RA (en) | Antiviral compounds | |
HK1208677A1 (en) | Antiviral compounds with an imidazole - biphenyl - imidazole core -- | |
HK1199454A1 (en) | Antiviral compounds | |
EP2585073A4 (en) | Antiviral compounds | |
HK1204618A1 (en) | Antiviral compounds | |
EP2699241A4 (en) | Antiviral compounds | |
GB201306947D0 (en) | Novel antiviral compounds | |
ZA201402374B (en) | Antiviral compounds | |
GB201121309D0 (en) | Antiviral |